发明名称 Aminobenzophenones functioning as IL-1beta a TNF-alpha inhibitors
摘要 <p>The present invention relates to compounds of formula (I) wherein R1 and R2 independently represent one or more, same or different substituents selected from the group consisting of halogen, hydroxy, mercapto, trifluoromethyl, amino (C1-C3)alkyl, (C2-C3)olefinic group, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, cyano, carbamoyl, phenyl, or nitro; R2 further being represented by hydrogen; R3 represents hydrogen, halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1-C3)alkyl, (C2-C3)olefinic group, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, phenyl, cyano, carboxy or carbomoyl; R4 represents hydrogen, (C1-C3)alkyl, or allyl; X represents oxygen or sulpher; with the proviso that formula (I) does not comprise the compound 2,2,2-trifluoro-N-[2-[3-chloro-4-(2-methylbenzoyl)-phenylamino]-phenyl]acetamide wherein R1 is a 2-methyl, R2 is 2-chloro, R3 and R4 is hydrogen, and X is oxygen; and a salt thereof with a pharmaceutically acceptable acid, a hydrate or a solvate thereof. The compounds are valuable in the human and veterinary therapy.</p>
申请公布号 CZ20020158(A3) 申请公布日期 2002.08.14
申请号 CZ20020000158 申请日期 2000.07.11
申请人 LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMIS 发明人 OTTOSEN ERIK RYTTER
分类号 A61P1/00;A61K31/165;A61K31/167;A61K45/06;A61P9/10;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P19/06;A61P19/10;A61P29/00;A61P31/04;A61P31/18;A61P37/08;C07C225/22;C07C233/43;(IPC1-7):C07C233/43;A61P37/00 主分类号 A61P1/00
代理机构 代理人
主权项
地址